Psittacosis

Revision as of 16:50, 12 August 2011 by Mohammed Sbeih (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Template:DiseaseDisorder infobox

WikiDoc Resources for Psittacosis

Articles

Most recent articles on Psittacosis

Most cited articles on Psittacosis

Review articles on Psittacosis

Articles on Psittacosis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Psittacosis

Images of Psittacosis

Photos of Psittacosis

Podcasts & MP3s on Psittacosis

Videos on Psittacosis

Evidence Based Medicine

Cochrane Collaboration on Psittacosis

Bandolier on Psittacosis

TRIP on Psittacosis

Clinical Trials

Ongoing Trials on Psittacosis at Clinical Trials.gov

Trial results on Psittacosis

Clinical Trials on Psittacosis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Psittacosis

NICE Guidance on Psittacosis

NHS PRODIGY Guidance

FDA on Psittacosis

CDC on Psittacosis

Books

Books on Psittacosis

News

Psittacosis in the news

Be alerted to news on Psittacosis

News trends on Psittacosis

Commentary

Blogs on Psittacosis

Definitions

Definitions of Psittacosis

Patient Resources / Community

Patient resources on Psittacosis

Discussion groups on Psittacosis

Patient Handouts on Psittacosis

Directions to Hospitals Treating Psittacosis

Risk calculators and risk factors for Psittacosis

Healthcare Provider Resources

Symptoms of Psittacosis

Causes & Risk Factors for Psittacosis

Diagnostic studies for Psittacosis

Treatment of Psittacosis

Continuing Medical Education (CME)

CME Programs on Psittacosis

International

Psittacosis en Espanol

Psittacosis en Francais

Business

Psittacosis in the Marketplace

Patents on Psittacosis

Experimental / Informatics

List of terms related to Psittacosis

For the WikiPatient page for this topic, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

In medicine (pulmonology), psittacosis -- also known as parrot disease, parrot fever, and ornithosis -- is a zoonotic infectious disease caused by a bacterium called Chlamydophila psittaci (formerly Chlamydia psittaci) and contracted not only from parrots, such as macaws, cockatiels and budgerigars, but also from pigeons, sparrows, ducks, hens, sea gulls and many other species of bird. The incidence of infection in canaries and finches is believed to be lower than in psittacine birds.

Symptoms

In humans, after incubation period of 5-14 days, the symptoms of the disease range from inapparent illness to systemic illness with severe pneumonia. It presents chiefly as an atypical pneumonia. In the first week of psittacosis the symtoms mimic typhoid fever: prostrating high fevers, arthralgias, diarrhea, conjunctivitis, epistaxis and leukopenia. Rose spots can appear and these are called Horder's spots. Splenomegaly is frequent toward the end of first week. Diagnosis can be suspected in case of respiratory infection associated with splenomegaly and/or epistaxis. Headache can be so severe that suggests meningitis and some nuchal rigidity is not unusual. Towards the end of first week stupor or even coma can result in severe cases.

The second week is more akin of acute bacteraemic pneumococcal pneumonia with continuous high fevers, cough and dyspnoea. X rays show patchy infiltrates or a diffuse whiteout of lung fields.

Bloodwork shows leukopenia, thrombocytopenia and moderately elevated liver enzymes.

Differential diagnosis must be made with typhus, typhoid and atypical pneumonia by Mycoplasma, Legionella or Q fever. Exposure history is paramout to diagnosis.

Complications in the form of endocarditis, hepatitis, myocarditis, arthritis, keratoconjunctivitis, and neurologic complications (encephalitis) may occasionally occur. Severe pneumonia requiring intensive-care support may also occur. Fatal cases have been reported (less than 1% of cases).

Diagnosis

Diagnosis involves microbiological cultures from respiratory secretions of patients or serologically with a fourfold or greater increase in antibody titers against C. psittaci in blood samples combined with the probable course of the disease. Typical inclusions called Leventhal -Colle-Lillie bodies can be seen within macrophages in BAL fluid. Culture of Chlamydia psittaci is hazardous and should only be carried out in biosafety laboratories.

Epidemiology

Since 1996, fewer than 50 confirmed cases were reported in the United States each year. Many more cases may occur that are not correctly diagnosed or reported.

Bird owners, pet shop employees, and veterinarians are at risk of the infection. Some outbreaks of psittacosis in poultry processing plants have been reported.

Treatment

The infection is treated with antibiotics. Tetracyclines and chloramphenicol are the drugs of choice for treating patients with psittacosis. Most persons respond to oral therapy (100 mg of doxycycline administered twice a day , 500 mg of tetracycline hydrochloride administered four times a day) or 500 mg of chloramphenicol palmitate orally every 6 hours. For initial treatment of severely ill patients, doxycycline hyclate may be administered intravenously at a dosage of 4.4 mg/kg (2 mg/lb) body weight per day divided into two infusions per day (up to 100 mg per dose). In past years, tetracycline hydrochloride has been administered to patients intravenously (10-15 mg/kg body weight per day divided into four doses per day). Remission of symptoms usually is evident within 48-72 hours. However, relapse can occur, and treatment must continue for at least 10-14 days after fever abates. Although its in vivo efficacy has not been determined, erythromycin probably is the best alternative agent for persons for whom tetracycline is contraindicated (e.g., children aged less than 9 years and pregnant women).

Source

  • The initial content for this article was adapted from sources available at http://www.cdc.gov.

External links

Avian

Human

Template:Bacterial diseases Template:SIB

da:Psittacosis de:Ornithose hr:Psitakoza it:Psittacosi no:Papegøyesyke simple:Psittacosis fi:Papukaijakuume sv:Papegojsjuka


Template:WikiDoc Sources